1-7 of 7
Andrew J. Yee
Close
Save search
Sort by
Journal Articles

Impact of clonal hematopoiesis on clinical outcomes to BCMA CAR-T in multiple myeloma

Open Access
Clinical Trials & Observations
Joshua N Gustine, Andrew R. Branagan, Diana D. Cirstea, Farah Rexha, Ryan Han, Andrew J. Yee, Marcela V. Maus, Matthew J. Frigault, Noopur S. Raje
Journal: Blood Advances
Blood Adv bloodadvances.2025015981.
https://doi.org/10.1182/bloodadvances.2025015981
Published: 2025
Includes: Supplemental data
Journal Articles

Early daratumumab therapy improves renal outcomes in newly diagnosed myeloma patients admitted with kidney injury

Open Access
Clinical Trials & Observations
E. Bridget Kim, Jack E. Malespini, Matthew Lei, Samuel S. Han, Cole W. Minsky, Andrew R. Branagan, Elizabeth K. O'Donnell, Diana D. Cirstea, Noopur S. Raje, Andrew J. Yee
Journal: Blood Advances
Blood Adv bloodadvances.2025015901.
https://doi.org/10.1182/bloodadvances.2025015901
Published: 2025
Includes: Supplemental data
Journal Articles

Elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma

Open Access
Clinical Trials & Observations
Andrew J. Yee, Jacob P. Laubach, Erica L. Campagnaro, Brea C. Lipe, Omar Nadeem, Robb S. Friedman, Craig E. Cole, Elizabeth K. O’Donnell, Giada Bianchi, Andrew R. Branagan, Robert L. Schlossman, Samantha J. Shapiro, Cynthia C. Harrington, Jill N. Burke, Marilyn T. Gammon, Kathleen J. Lively, Cassandra A. Reimonn, Danielle X. Andrade, Robert Redd, Jens G. Lohr, Kenneth C. Anderson, Paul G. Richardson, Noopur S. Raje
Journal: Blood Advances
Blood Adv (2025) 9 (5): 1163–1170.
https://doi.org/10.1182/bloodadvances.2024014717
Published: 2025
Includes: Supplemental data
Journal Articles

Nivolumab to restore T-cell fitness in CAR-T refractory multiple myeloma

Open Access
Clinical Trials & Observations
Johannes M. Waldschmidt, Noori Sotudeh, Sankalp Arora, Tushara Vijaykumar, Praveen Anand, Hannah Stuart, Julia Frede, Tim Campbell, Shari M. Kaiser, Xirong Zheng, Nikhil C. Munshi, Kenneth C. Anderson, Hermann Einsele, Andrew J. Yee, Birgit Knoechel, Jens G. Lohr, Noopur S. Raje
Journal: Blood Advances
Blood Adv (2025) 9 (5): 1132–1136.
https://doi.org/10.1182/bloodadvances.2024015285
Published: 2025
Includes: Supplemental data
Journal Articles

Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma

Free
Clinical Trials & Observations
Matthew J. Frigault, Michael R. Bishop, Jacalyn Rosenblatt, Elizabeth K. O’Donnell, Noopur Raje, Daniella Cook, Andrew J. Yee, Emma Logan, David E. Avigan, Andrzej Jakubowiak, Kit Shaw, Heather Daley, Sarah Nikiforow, Faith Griffin, Christine Cornwell, Angela Shen, Christopher Heery, Marcela V. Maus
Journal: Blood Advances
Blood Adv (2023) 7 (5): 768–777.
https://doi.org/10.1182/bloodadvances.2022007210
Published: 2023
Includes: Supplemental data
Journal Articles

Quality of life, psychological distress, and prognostic perceptions in caregivers of patients with multiple myeloma

Free
Elizabeth K. O’Donnell, Yael N. Shapiro, Andrew J. Yee, Omar Nadeem, Jacob P. Laubach, Andrew R. Branagan, Kenneth C. Anderson, Clifton C. Mo, Nikhil C. Munshi, Irene M. Ghobrial, Adam S. Sperling, Emerentia A. Agyemang, Jill N. Burke, Cynthia C. Harrington, Bonnie Y. Hu, Paul G. Richardson, Noopur S. Raje, Areej El-Jawahri
Journal: Blood Advances
Blood Adv (2022) 6 (17): 4967–4974.
https://doi.org/10.1182/bloodadvances.2022007127
Published: 2022
Journal Articles

Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study

Free
Clinical Trials & Observations
Gareth P. Gregory, Shaji Kumar, Ding Wang, Daruka Mahadevan, Patricia Walker, Nina Wagner-Johnston, Carolina Escobar, Rajat Bannerji, Divaya Bhutani, Julie Chang, Francisco J. Hernandez-Ilizaliturri, Andreas Klein, John M. Pagel, Witold Rybka, Andrew J. Yee, Anne Mohrbacher, Mo Huang, Mohammed Farooqui, Patricia Marinello, Hang Quach
Journal: Blood Advances
Blood Adv (2022) 6 (4): 1232–1242.
https://doi.org/10.1182/bloodadvances.2021005872
Published: 2022
Includes: Supplemental data